FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Sneed Michael E

2. Date of Event Requiring Statement (MM/DD/YYYY)
7/2/2018 

3. Issuer Name and Ticker or Trading Symbol

JOHNSON & JOHNSON [JNJ]

(Last)        (First)        (Middle)

ONE JOHNSON & JOHNSON PLAZA

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
EVP, Global Corp Aff & COO /

(Street)

NEW BRUNSWICK, NJ 08933       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   30124.0000   D    
Common Stock   2277.0000   (1) I   By 401k  
Common Stock   1268.0000   (2) I   By ESOP  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Options (Right to Buy)   (3) 2/10/2012   2/8/2019   Common Stock   59943.0000   $58.3300   D    
Employee Stock Options (Right to Buy)   (3) 1/11/2014   1/8/2021   Common Stock   54662.0000   $62.2000   D    
Employee Stock Options (Right to Buy)   (3) 2/9/2013   2/7/2020   Common Stock   58128.0000   $62.6200   D    
Employee Stock Options (Right to Buy)   (3) 1/18/2015   1/17/2022   Common Stock   58555.0000   $65.3700   D    
Employee Stock Options (Right to Buy)   (3) 1/17/2016   1/13/2023   Common Stock   75385.0000   $72.5400   D    
Employee Stock Options (Right to Buy)   (3) 2/11/2017   2/9/2024   Common Stock   55435.0000   $90.4400   D    
Employee Stock Options (Right to Buy)   (3) 2/10/2018   2/9/2025   Common Stock   40569.0000   $100.0600   D    
Employee Stock Options (Right to Buy)   (3) 2/9/2019   2/8/2026   Common Stock   42145.0000   $101.8700   D    
Employee Stock Options (Right to Buy)   (3) 2/13/2020   2/13/2027   Common Stock   32167.0000   $115.6700   D    
Employee Stock Options (Right to Buy)   (3) 2/12/2021   2/11/2028   Common Stock   29372.0000   $129.5100   D    
Restricted Share Units   (4) 2/8/2019     (4) Common Stock   6365.0000     (4) D    
Restricted Share Units   (4) 2/12/2021     (4) Common Stock   1474.0000     (4) D    
Restricted Share Units   (4) 2/13/2020     (4) Common Stock   5684.0000     (4) D    

Explanation of Responses:
(1)  Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2018).
(2)  Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2018).
(3)  Vested and exercisable one day after the third anniversary of the date of the grant.
(4)  Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Sneed Michael E
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933

EVP, Global Corp Aff & COO

Signatures
Linda E King, as attorney-in-fact for Michael E. Sneed 7/11/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Johnson and Johnson Charts.